Case Comprehensive Cancer Center

Teams from Case CCC and University Hospitals have received Collaborative Pilot Science Awards to conduct research on brain tumor, cerebral edema, and gastroesophageal cancer. Each team received $50,000 funded by the UH-CWRU Joint Strategic Leadership Committee. According to Daniel Simon, MD, UH's ...

The brainchild of John Wang, PhD, Co-Leader of Case CCC's Cancer Genomics and Epigenomics Program, the Emerging Researchers Program welcomed four returning students and two new students this week—all from East Cleveland. With the support of Frances Payne Bolton School of Nursing, CWRU's Faye Gary, ...

University Hospitals Newsroom CLEVELAND – Data from a new study published in NEJM Evidence shows promise for personalized use of short term ADT in men with predominantly intermediate-risk prostate cancer. The study involved ArteraAI, a developer of multimodal artificial intelligence-based predictiv...

A new three-year, $2.5 million grant from Stand Up To Cancer® (SU2C) has been awarded to a multi-institutional team of gastroesophageal cancer experts, led by Anil K. Rustgi, MD, director of the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Irving Med...

A standing-room-only audience of Cleveland high school students and their families attended orientation for the 20th Annual Scientific Enrichment and Opportunity (SEO) and Youth Engaged in Science (YES) programs on June 5. Students were treated to an inspirational and motivational address by Edward ...

Ruth Keri, PhD, member of Case CCC's Molecular Oncology Program, and her colleagues have discovered that CDK7 is a core regulator of chromosomal architecture that functions, in part, by sustaining the expression of the condensin complex. By conducting multiple studies, they discovered that CDK7 inh...

A new study, conducted by Justin Lathia, PhD, co-leader of Case CCC's Molecular Oncology Program, and published in the journal Nature Cancer, is the topic of conversation in the most recent issue of the NIH Director's Blog. According to Lawrence Tabak, DDS, PhD, acting director of the National Inst...

Nominated by his students, Jason Mears, PhD, Case CCC Molecular Oncology Program member, received the 2023 John S. Diekhoff Award for Graduate Mentoring. The Diekhoff Award recognizes outstanding contributions to the education of graduate students through advising and classroom teaching. In 2009, i...

Research by Kishore Guda, DVM, PhD, Case CCC's Cancer Genomics and Epigenomics Program member, published this month in Gastroenterology indicates that biomarkers in throat cells may predict an individual's predisposition to developing esophageal cancer. “Our study opens a new area of investigation ...

Case CCC proudly introduces the 2023 cohort of CanSUR Scholars. These diverse students from universities across the nation begin training in Cleveland at the end of May. Directed by Mark Jackson, PhD, Associate Director for Cancer Training and Education, the program this year attracted 320 applicat...